Catalyst Health Solutions opened at 86.97 on Tuesday. Catalyst Health Solutions has a 1-year low of $45.35 and a 1-year high of $92.62. The company has a market cap of $4.284 billion and a price-to-earnings ratio of 64.90.
Catalyst Health Solutions last released its earnings data on Thursday, May 3rd. The company reported $0.62 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.59 by $0.03. Catalyst Health Solutions’s revenue was up 29.7% compared to the same quarter last year. Analysts expect that Catalyst Health Solutions will post $0.69 EPS next quarter.
A number of other firms have also recently commented on CHSI. Analysts at Zacks reiterated a “neutral” rating on shares of Catalyst Health Solutions in a research note to investors on Monday, May 7th. They now have a $91.00 price target on the stock. Finally, analysts at BMO Capital Markets downgraded shares of Catalyst Health Solutions from an “outperform” rating to a “market perform” rating in a research note to investors on Monday, April 23rd.
Catalyst Health Solutions, Inc. is a full-service pharmacy benefit management (PBM) company. The Company operates under the brand name Catalyst Rx.